Lifestyle · Exercise

Gas-exchange derived pulmonary vascular capacitance (GXCAP) and ventilatory efficiency (VE/VCO2) measured during submaximal exercise testing can identify non-severe PH-ILD patients with exercise-induced increases in pulmonary vascular resistance.

In 16 patients with non-severe pulmonary hypertension associated with interstitial lung disease, GXCAP was significantly higher in those with static PVR (471 ± 85 mL·mmHg) versus dynamic PVR (311 ± 38 mL·mmHg, p < 0.01), while VE/VCO2 was lower in static PVR (33 ± 2 vs 37 ± 2.5, p < 0.01). ROC analysis showed excellent discrimination for GXCAP (AUC 0.98) and good discrimination for VE/VCO2 (AUC 0.90) in identifying the dynamic PVR phenotype.

1 min readUpdated Jul 30, 20260 RCTsView structured evidence →
Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Gas-exchange derived pulmonary vascular capacitance (GXCAP) and ventilatory efficiency (VE/VCO2) measured during submaximal exercise testing can identify non-severe PH-ILD patients with exercise-induced increases in pulmonary vascular resistance. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).

The Claim

Gas-exchange derived pulmonary vascular capacitance (GXCAP) and ventilatory efficiency (VE/VCO2) measured during submaximal exercise testing can identify non-severe PH-ILD patients with exercise-induced increases in pulmonary vascular resistance.

This conclusion is most relevant to: 16 patients with non-severe pulmonary hypertension associated with interstitial lung disease (PH-ILD).

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • Noninvasive Gas Exchange Determinants of Exercise Hemodynamics in Non-Severe Pulmonary Hypertension Associated With Interstitial Lung Disease. (Pulmonary circulation, 2026) —

How It Works

The proposed biological pathway:

  • Submaximal exercise testing is performed to measure gas-exchange parameters
  • GXCAP and VE/VCO2 are calculated from exhaled gases
  • Lower GXCAP and higher VE/VCO2 indicate dynamic pulmonary vascular impairment
  • These markers correlate with invasive hemodynamic measures of exercise-induced PVR increase

Who Might Benefit

Evidence fit by population:

  • 16 patients with non-severe pulmonary hypertension associated with interstitial lung disease (PH-ILD)

Limitations & Caveats

Important context when interpreting this evidence:

  • Retrospective study design with small sample size (n=16)
  • Validation in larger prospective cohorts is needed before clinical application

Frequently Asked Questions

What is GXCAP?

GXCAP is a gas-exchange derived estimate of pulmonary vascular capacitance, calculated from submaximal exercise testing data.

How does VE/VCO2 relate to pulmonary vascular disease?

Higher VE/VCO2 indicates worse ventilatory efficiency and is associated with increased pulmonary vascular resistance during exercise.

Can these tests replace invasive catheterization?

The study suggests they may serve as noninvasive alternatives for identifying exercise-induced pulmonary vascular impairment, but invasive testing remains the gold standard.

What population was studied?

Patients with non-severe pulmonary hypertension associated with interstitial lung disease (PH-ILD).

References

  1. 1.Dagher C, Moallem N, Fiscus G, Carollo B, Swanson K, Farber HW, Parikh R. “Noninvasive Gas Exchange Determinants of Exercise Hemodynamics in Non-Severe Pulmonary Hypertension Associated With Interstitial Lung Disease..” Pulmonary circulation, 2026. PMID: 42516687 DOI: 10.1002/pul2.70358
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.